the effect of magnesium on pain relief
Phase 3
- Conditions
- major abdominal surgery.personal history of major abdominal surgeryz92.4
- Registration Number
- IRCT20210214050359N1
- Lead Sponsor
- Mashhad University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 84
Inclusion Criteria
Candidates for major abdominal surgery
Candidates for icu after abdominal surgery
Exclusion Criteria
heart failure
renal failure
hepatic failure
sensitivity to magnesium sulfate
poisoning to magnesium sulfate
drug abuse
neuromuscular disease
Dissatisfaction
Lack of cooperation
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pain. Timepoint: every 3 hours. Method of measurement: After the necessary training to the patient, pain intensity is measured every 3 hours for 24 hours based on the unit of numerical pain rating scale.;Level of Prescription morphin. Timepoint: every 3 hours. Method of measurement: The total morphine injected in the first 24 hours of entering the ICU to reduce the severity of pain is calculated to be less than 3.;Level of serum magnesium sulfate. Timepoint: Upon arrival and after 24 hours. Method of measurement: Serum magnesium sulfate levels are measured by blood sample at the time of entry into the ICU and after 24 hours.
- Secondary Outcome Measures
Name Time Method Blood pressure. Timepoint: every 3 hours. Method of measurement: Sphygmomanometer.;Respiratory rate. Timepoint: every 3 hour. Method of measurement: counting respiratory rate in 1 minute.;Pulse rate. Timepoint: every 3 hours. Method of measurement: pulseoxymetery.;O2 saturation. Timepoint: every 3 hours. Method of measurement: pulseoxymetery.